IL155677A0 - Cyclization process step in the making of quinolones and naphthyridines - Google Patents

Cyclization process step in the making of quinolones and naphthyridines

Info

Publication number
IL155677A0
IL155677A0 IL15567701A IL15567701A IL155677A0 IL 155677 A0 IL155677 A0 IL 155677A0 IL 15567701 A IL15567701 A IL 15567701A IL 15567701 A IL15567701 A IL 15567701A IL 155677 A0 IL155677 A0 IL 155677A0
Authority
IL
Israel
Prior art keywords
making
naphthyridines
quinolones
process step
cyclization process
Prior art date
Application number
IL15567701A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL155677A0 publication Critical patent/IL155677A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL15567701A 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines IL155677A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25563300P 2000-12-14 2000-12-14
PCT/US2001/048536 WO2002048113A1 (en) 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines

Publications (1)

Publication Number Publication Date
IL155677A0 true IL155677A0 (en) 2003-11-23

Family

ID=22969207

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15567701A IL155677A0 (en) 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines
IL155677A IL155677A (en) 2000-12-14 2003-04-30 Stage cyclization in the process of preparing quinolones and naphthyridines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155677A IL155677A (en) 2000-12-14 2003-04-30 Stage cyclization in the process of preparing quinolones and naphthyridines

Country Status (19)

Country Link
EP (1) EP1343766B1 (xx)
JP (2) JP4417007B2 (xx)
KR (1) KR100603163B1 (xx)
CN (1) CN1232508C (xx)
AT (1) ATE300522T1 (xx)
AU (2) AU2905702A (xx)
BR (1) BR0116229A (xx)
CA (1) CA2427831C (xx)
CZ (1) CZ20031379A3 (xx)
DE (1) DE60112325T2 (xx)
DK (1) DK1343766T3 (xx)
ES (1) ES2247190T3 (xx)
HU (1) HUP0303991A3 (xx)
IL (2) IL155677A0 (xx)
MX (1) MXPA03005338A (xx)
NO (1) NO325236B1 (xx)
NZ (1) NZ525569A (xx)
PL (1) PL207394B1 (xx)
WO (1) WO2002048113A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100735587B1 (ko) * 2002-08-05 2007-07-04 더 프록터 앤드 갬블 캄파니 퀴놀론계 항생제 중간체의 제조 방법
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
CZ2004764A3 (cs) 2002-11-20 2005-02-16 Japan Tobacco Inc 4-Oxochinolinová sloučenina a její použití jako inhibitoru HIV-integrázy
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
US8420821B2 (en) 2006-03-06 2013-04-16 Japan Tobacco Inc. Process for production of 4-oxoquinoline compound
US8383819B2 (en) 2006-03-06 2013-02-26 Japan Tobacco Inc. Method for producing 4-oxoquinoline compound
CN101516819B (zh) * 2006-09-12 2013-10-16 吉里德科学公司 制备整合酶抑制剂的方法和中间体
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
US8211909B2 (en) 2008-07-01 2012-07-03 Taigen Biotechnology Co., Ltd. Treatment of antibiotic-resistant bacteria infection
AU2013296289B2 (en) 2012-08-03 2017-10-05 Gilead Sciences, Inc. Process and intermediates for preparing integrase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004286A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds

Also Published As

Publication number Publication date
KR20030063420A (ko) 2003-07-28
MXPA03005338A (es) 2003-10-06
WO2002048113A1 (en) 2002-06-20
HUP0303991A3 (en) 2012-09-28
CZ20031379A3 (cs) 2003-11-12
ATE300522T1 (de) 2005-08-15
HUP0303991A2 (hu) 2004-04-28
DK1343766T3 (da) 2005-10-31
DE60112325D1 (de) 2005-09-01
AU2002229057B2 (en) 2005-04-21
JP4417007B2 (ja) 2010-02-17
CN1481365A (zh) 2004-03-10
DE60112325T2 (de) 2006-05-24
NO325236B1 (no) 2008-03-03
NO20032667D0 (no) 2003-06-12
JP2010001315A (ja) 2010-01-07
EP1343766B1 (en) 2005-07-27
IL155677A (en) 2009-02-11
AU2905702A (en) 2002-06-24
CA2427831C (en) 2009-08-18
EP1343766A1 (en) 2003-09-17
CA2427831A1 (en) 2002-06-20
ES2247190T3 (es) 2006-03-01
NO20032667L (no) 2003-08-14
CN1232508C (zh) 2005-12-21
NZ525569A (en) 2004-09-24
BR0116229A (pt) 2003-11-04
KR100603163B1 (ko) 2006-07-24
PL207394B1 (pl) 2010-12-31
JP2004515542A (ja) 2004-05-27
PL363355A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
NZ536141A (en) Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
RS86804A (xx) Derivati hinolina i izohinolina, postupak za njihovo dobijanje i njihova primena kao supresora zapaljenja
SG141459A1 (en) Novel quinoline derivatives
MXPA03009600A (es) Analogos de nociceptina.
AU2905702A (en) Cyclization process step in the making of quinolones and naphthyridines
WO2003018588A3 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
ATE339427T1 (de) Herstellung von sekundären aminoisobutylalkoxysilanen
IL154014A0 (en) Process for the preparation of 2-aminoethylpyridines
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
IL156141A0 (en) A process for the preparation of taxan derivatives
MXPA04004937A (es) Proceso para preparar 3,3??,3,6??,-tetraalquil-2,2??-bifenoles y 3,??,6,??-tetraalquil-5,??-dihalo-2,??-bifenoles.
GB0019124D0 (en) Novel process
IN187760B (xx)
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
AU2002233708A1 (en) Process for producing quinoline-3-carboxylic acid compound
IL185920A0 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
TR200200995T2 (tr) 7-amino-3-metksimetil-3-sefem-4-karbosilik asitin hazırlanmasına yönelik proses.
MXPA04003519A (es) Procedimiento para la preparacion del 14beta-hidroxi-bacatina iii-1,14-carbonato.
SE0000382D0 (sv) New process
WO2003044877A3 (en) Light emitting device and compounds for use therein
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
AUPR080300A0 (en) Improvement to mobile (cellular) phone refered to as "the brett test"
PL368635A1 (en) Process for the production of low ash fuel
HU0101842D0 (en) Korturek variety of tearose hybrid (rosa l.)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed